251 related articles for article (PubMed ID: 29535271)
1. Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study.
Dijkland SA; Voormolen DC; Venema E; Roozenbeek B; Polinder S; Haagsma JA; Nieboer D; Chalos V; Yoo AJ; Schreuders J; van der Lugt A; Majoie CBLM; Roos YBWEM; van Zwam WH; van Oostenbrugge RJ; Steyerberg EW; Dippel DWJ; Lingsma HF;
Stroke; 2018 Apr; 49(4):965-971. PubMed ID: 29535271
[TBL] [Abstract][Full Text] [Related]
2. Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale.
Chaisinanunkul N; Adeoye O; Lewis RJ; Grotta JC; Broderick J; Jovin TG; Nogueira RG; Elm JJ; Graves T; Berry S; Lees KR; Barreto AD; Saver JL; ;
Stroke; 2015 Aug; 46(8):2238-43. PubMed ID: 26138130
[TBL] [Abstract][Full Text] [Related]
3. Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients.
Wang X; Moullaali TJ; Li Q; Berge E; Robinson TG; Lindley R; Zheng D; Delcourt C; Arima H; Song L; Chen X; Yang J; Chalmers J; Anderson CS; Sandset EC
Stroke; 2020 Aug; 51(8):2411-2417. PubMed ID: 32640944
[TBL] [Abstract][Full Text] [Related]
4. Utility-weighted modified Rankin Scale: Still too crude to be a truly patient-centric primary outcome measure?
Rethnam V; Bernhardt J; Dewey H; Moodie M; Johns H; Gao L; Collier J; Ellery F; Churilov L;
Int J Stroke; 2020 Apr; 15(3):268-277. PubMed ID: 30747612
[TBL] [Abstract][Full Text] [Related]
5. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
[TBL] [Abstract][Full Text] [Related]
6. Health Utility Weighting of the Modified Rankin Scale: A Systematic Review and Meta-analysis.
Rebchuk AD; O'Neill ZR; Szefer EK; Hill MD; Field TS
JAMA Netw Open; 2020 Apr; 3(4):e203767. PubMed ID: 32347948
[TBL] [Abstract][Full Text] [Related]
7. Quality of life after intra-arterial treatment for acute ischemic stroke in the MR CLEAN trial-Update.
Schreuders J; van den Berg LA; Fransen PS; Berkhemer OA; Beumer D; Lingsma HF; van Oostenbrugge RJ; van Zwam WH; Majoie CB; van der Lugt A; de Kort PL; Roos YB; Dippel DW;
Int J Stroke; 2017 Oct; 12(7):708-712. PubMed ID: 28436305
[TBL] [Abstract][Full Text] [Related]
8. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.
Chalos V; van der Ende NAM; Lingsma HF; Mulder MJHL; Venema E; Dijkland SA; Berkhemer OA; Yoo AJ; Broderick JP; Palesch YY; Yeatts SD; Roos YBWEM; van Oostenbrugge RJ; van Zwam WH; Majoie CBLM; van der Lugt A; Roozenbeek B; Dippel DWJ;
Stroke; 2020 Jan; 51(1):282-290. PubMed ID: 31795895
[TBL] [Abstract][Full Text] [Related]
9. Shift analysis versus dichotomization of the modified Rankin scale outcome scores in the NINDS and ECASS-II trials.
Savitz SI; Lew R; Bluhmki E; Hacke W; Fisher M
Stroke; 2007 Dec; 38(12):3205-12. PubMed ID: 17975102
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of patients with pre-existing disability managed by mobile stroke units: A sub-analysis of the BEST-MSU study.
Pirlog BO; Jacob AP; Rajan SS; Yamal JM; Parker SA; Wang M; Bowry R; Czap A; Bratina PL; Gonzalez MO; Singh N; Zou J; Gonzales NR; Jones WJ; Alexandrov AW; Alexandrov AV; Navi BB; Nour M; Spokoyny I; Mackey J; Silnes K; Fink ME; Pisarro Sherman C; Willey J; Saver JL; English J; Barazangi N; Ornelas D; Volpi J; Pv Rao C; Griffin L; Persse D; Grotta JC
Int J Stroke; 2023 Dec; 18(10):1209-1218. PubMed ID: 37337357
[TBL] [Abstract][Full Text] [Related]
11. Outcome Evaluation of Acute Ischemic Stroke Patients Treated with Endovascular Thrombectomy: A Single-Institution Experience in the Era of Randomized Controlled Trials.
Sarzetto F; Gupta S; Alotaibi NM; Howard P; da Costa L; Heyn C; Maralani PJ; Guha D; Swartz RH; Boyle K; Yang VXD
World Neurosurg; 2017 Mar; 99():593-598. PubMed ID: 28017746
[TBL] [Abstract][Full Text] [Related]
12. Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm.
Chen X; Li J; Anderson CS; Lindley RI; Hackett ML; Robinson T; Lavados PM; Wang X; Arima H; Chalmers J; Delcourt C;
Int J Stroke; 2021 Feb; 16(2):222-228. PubMed ID: 31969072
[TBL] [Abstract][Full Text] [Related]
13. Endovascular vs medical management of acute ischemic stroke.
Chen CJ; Ding D; Starke RM; Mehndiratta P; Crowley RW; Liu KC; Southerland AM; Worrall BB
Neurology; 2015 Dec; 85(22):1980-90. PubMed ID: 26537058
[TBL] [Abstract][Full Text] [Related]
14. Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial.
Menon BK; Qazi E; Nambiar V; Foster LD; Yeatts SD; Liebeskind D; Jovin TG; Goyal M; Hill MD; Tomsick TA; Broderick JP; Demchuk AM;
Stroke; 2015 May; 46(5):1239-44. PubMed ID: 25791716
[TBL] [Abstract][Full Text] [Related]
15. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
16. A randomized trial of intraarterial treatment for acute ischemic stroke.
Berkhemer OA; Fransen PS; Beumer D; van den Berg LA; Lingsma HF; Yoo AJ; Schonewille WJ; Vos JA; Nederkoorn PJ; Wermer MJ; van Walderveen MA; Staals J; Hofmeijer J; van Oostayen JA; Lycklama à Nijeholt GJ; Boiten J; Brouwer PA; Emmer BJ; de Bruijn SF; van Dijk LC; Kappelle LJ; Lo RH; van Dijk EJ; de Vries J; de Kort PL; van Rooij WJ; van den Berg JS; van Hasselt BA; Aerden LA; Dallinga RJ; Visser MC; Bot JC; Vroomen PC; Eshghi O; Schreuder TH; Heijboer RJ; Keizer K; Tielbeek AV; den Hertog HM; Gerrits DG; van den Berg-Vos RM; Karas GB; Steyerberg EW; Flach HZ; Marquering HA; Sprengers ME; Jenniskens SF; Beenen LF; van den Berg R; Koudstaal PJ; van Zwam WH; Roos YB; van der Lugt A; van Oostenbrugge RJ; Majoie CB; Dippel DW;
N Engl J Med; 2015 Jan; 372(1):11-20. PubMed ID: 25517348
[TBL] [Abstract][Full Text] [Related]
17. Effect Size Estimates for the ESCAPE Trial: Proportional Odds Regression Versus Other Statistical Methods.
Sajobi TT; Zhang Y; Menon BK; Goyal M; Demchuk AM; Broderick JP; Hill MD
Stroke; 2015 Jul; 46(7):1800-5. PubMed ID: 26022639
[TBL] [Abstract][Full Text] [Related]
18. Association of Computed Tomography Ischemic Lesion Location With Functional Outcome in Acute Large Vessel Occlusion Ischemic Stroke.
Ernst M; Boers AMM; Aigner A; Berkhemer OA; Yoo AJ; Roos YB; Dippel DWJ; van der Lugt A; van Oostenbrugge RJ; van Zwam WH; Fiehler J; Marquering HA; Majoie CBLM;
Stroke; 2017 Sep; 48(9):2426-2433. PubMed ID: 28765288
[TBL] [Abstract][Full Text] [Related]
19. Regression analysis of ordinal stroke clinical trial outcomes: an application to the NINDS t-PA trial.
Desantis SM; Lazaridis C; Palesch Y; Ramakrishnan V
Int J Stroke; 2014 Feb; 9(2):226-31. PubMed ID: 23803174
[TBL] [Abstract][Full Text] [Related]
20. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
